Open original FDA record ↗Recall record
- FDA identifier
- Z-2184-2018
- Company in FDA record
- Cellavision AB
- FDA record creation date
- Jun 13, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A software malfunction was found where WBC, RBC and PLT comments added after a slide is signed, are not sent to the LIS. This can only occur where customers process multiple slides per blood sample.
Source facts
- Action
- CellaVision sent an Urgent Medical Device Recall letter dated December 4, 2017. The letter identified affected product, problem and the actions to be taken. Customers are requested to determine if they are affected or not. If affected they are requested to contact their local distributor for installing a patch. Customers are asked to confirm receipt of the notice by signing and dating the attached Acknowledgement Form and emailing a copy to their local distributor. For technical questions contact CelleVision (service@cellavision.se)
- Initiated
- 2017-12-04
- Root cause
- Software design
- Distribution
- US Nationwide in the states of FL, IL, NY, and NC
- Recall number
- Z-2184-2018
- Recall status
- Open, Classified
- CDRH record ID
- 164663
- FDA record created
- 2018-06-13
- Recall event number
- 80137